Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve To Consider and approve the Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2026.